全文获取类型
收费全文 | 12666篇 |
免费 | 897篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 499篇 |
妇产科学 | 200篇 |
基础医学 | 1610篇 |
口腔科学 | 147篇 |
临床医学 | 1380篇 |
内科学 | 2530篇 |
皮肤病学 | 198篇 |
神经病学 | 1197篇 |
特种医学 | 357篇 |
外国民族医学 | 2篇 |
外科学 | 1747篇 |
综合类 | 174篇 |
一般理论 | 11篇 |
预防医学 | 1068篇 |
眼科学 | 526篇 |
药学 | 1038篇 |
中国医学 | 24篇 |
肿瘤学 | 776篇 |
出版年
2023年 | 59篇 |
2022年 | 111篇 |
2021年 | 293篇 |
2020年 | 169篇 |
2019年 | 250篇 |
2018年 | 307篇 |
2017年 | 261篇 |
2016年 | 262篇 |
2015年 | 332篇 |
2014年 | 411篇 |
2013年 | 618篇 |
2012年 | 968篇 |
2011年 | 973篇 |
2010年 | 527篇 |
2009年 | 442篇 |
2008年 | 760篇 |
2007年 | 851篇 |
2006年 | 793篇 |
2005年 | 806篇 |
2004年 | 718篇 |
2003年 | 677篇 |
2002年 | 615篇 |
2001年 | 158篇 |
2000年 | 141篇 |
1999年 | 141篇 |
1998年 | 158篇 |
1997年 | 122篇 |
1996年 | 81篇 |
1995年 | 94篇 |
1994年 | 109篇 |
1993年 | 77篇 |
1992年 | 104篇 |
1991年 | 94篇 |
1990年 | 73篇 |
1989年 | 85篇 |
1988年 | 86篇 |
1987年 | 55篇 |
1986年 | 67篇 |
1985年 | 65篇 |
1984年 | 57篇 |
1983年 | 53篇 |
1982年 | 69篇 |
1981年 | 58篇 |
1980年 | 46篇 |
1979年 | 56篇 |
1978年 | 44篇 |
1977年 | 33篇 |
1974年 | 25篇 |
1973年 | 30篇 |
1972年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
62.
63.
Gary P Zaloga Rafat Siddiqui Colin Terry Paul E Marik 《Nutrition in clinical practice》2004,19(3):201-215
Arginine is a conditionally essential amino acid that plays pivotal roles in maintaining body homeostasis. Arginine is a substrate for protein synthesis but can also be metabolized to various bioactive compounds that include nitric oxide, ornithine, polyamines, creatine phosphate, agmatine, and dimethylarginines. Arginine produces physiologic effects via nitric oxide dependent and independent pathways. Nitric oxide is important for the modulation of vascular tone, inflammation, immune function, endothelial function, platelet and leukocyte adherence, and neurotransmission. Nitric oxide modulates many biochemical processes important for the response to sepsis. Arginine, independent of nitric oxide, is important for growth, wound healing, cardiovascular function, immune function, inflammatory responses, energy metabolism, urea cycle function, and other metabolic processes. Arginine supplementation improves outcomes in animals with sepsis, wounds, ischemia-reperfusion injury, and following thermal injury. Enteral administration of arginine improves endothelial function but has little effect upon hemodynamics during human sepsis. An analysis of clinical studies using enteral formulas with supplemental arginine suggests benefits upon outcome, with no evidence of significant detrimental effects. 相似文献
64.
65.
66.
67.
Ru-Jin Huang Thorsten Hoffmann Jurgita Ovadnevaite Ari Laaksonen Harri Kokkola Wen Xu Wei Xu Darius Ceburnis Renyi Zhang John H. Seinfeld Colin ODowd 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(32)
The gas-phase formation of new particles less than 1 nm in size and their subsequent growth significantly alters the availability of cloud condensation nuclei (CCN, >30–50 nm), leading to impacts on cloud reflectance and the global radiative budget. However, this growth cannot be accounted for by condensation of typical species driving the initial nucleation. Here, we present evidence that nucleated iodine oxide clusters provide unique sites for the accelerated growth of organic vapors to overcome the coagulation sink. Heterogeneous reactions form low-volatility organic acids and alkylaminium salts in the particle phase, while further oligomerization of small α-dicarbonyls (e.g., glyoxal) drives the particle growth. This identified heterogeneous mechanism explains the occurrence of particle production events at organic vapor concentrations almost an order of magnitude lower than those required for growth via condensation alone. A notable fraction of iodine associated with these growing particles is recycled back into the gas phase, suggesting an effective transport mechanism for iodine to remote regions, acting as a “catalyst” for nucleation and subsequent new particle production in marine air.Marine aerosol formation contributes significantly to the global radiative budget given the high susceptibility of marine stratiform cloud radiative properties to changes in cloud condensation nuclei (CCN) availability. Atmospheric new-particle-formation is thought to involve nucleation of sulfuric acid with water, ammonia, or amines followed by condensation/growth in the presence of organic vapors (1, 2). Unique in the marine boundary layer (MBL), new particle formation involves sequential addition of HIO3 or clustering of iodine oxides (IxOy) (3, 4). In specific source regions such as coastal zones, seaweed beds, or snowpack/pack-ice, iodine oxide nucleation can be a driving force for nucleation (5–7). Over Arctic waters, nonetheless, one study finds insufficient iodic acid vapors to grow nucleated particles to CCN sizes (8), whereas another study finds that both nucleation and growth are almost exclusively driven by iodic acid (9). Over the open ocean, the supply of iodine oxides has been thought to be limited; however, recent measurements suggest that significant reactive iodine chemistry can occur in these regions (10). Moreover, observational evidence exists for open ocean particle formation and growth, especially when oceanic productivity is high (11, 12). An increase in atmospheric iodine levels in the North Atlantic since the mid-20th century has been shown to be driven by growth of anthropogenic ozone and enhanced subice phytoplankton production (13). While the reported IO concentration (0.4–3.1 ppt) in the remote MBL (10, 14, 15) is likely sufficient for formation of prenucleation clusters (∼1 nm), growth of these initial clusters requires the presence of other condensable vapors (16). Since preexisting aerosol particles act as a strong sink for the nucleated clusters, thus inhibiting atmospheric aerosol and CCN formation (17, 18), this early growth phase is essential for their survival. Whereas sulfuric acid vapor is also involved in nucleation, its level in remote open ocean is generally too low (105 molecules cm−3) to support subsequent particle growth, leaving organic vapors as the most plausible alternative for particle growth.In the marine atmosphere, condensing organics must originate from the oxidation of marine volatile organic compounds (VOCs), which predominantly comprise C1–C5 VOCs (e.g., isoprene) released from phytoplankton. Principal high volatility oxidation products consist of intermediate oxidized organics (IOOs), such as polyhydric alcohols (e.g., tetrols) or polyfunctional carbonyls (e.g., glyoxal) (19–22). Nonetheless, growth of available prenucleation clusters/nanometer particles requires condensing organic molecules of low effective volatilities (i.e., saturation mass concentration, C* < ∼10−3 μg m−3); otherwise, preferential condensation of the organic mass to larger-diameter particles would occur (23, 24). Formation of such extremely low-volatility organic compounds (ELVOCs) from gas-phase reaction is well established for monoterpene oxidation products (25, 26).A potential pathway for formation of low-volatility organics could also result from particle-phase chemical reactions induced by iodine oxides in the early stages of marine particle formation. When the underlying chemistry is sufficiently fast, kinetic condensation occurs, resulting in particles with diameters smaller than about 50 nm growing at the same rate (e.g., nm h−1) (24). If, however, particle-phase chemistry is preferentially favored in the smallest particles (i.e., stemming from the higher relative concentration of iodine oxides in freshly formed marine particles), growth of the nucleated particles could proceed more rapidly, as compared to that in which gas-phase chemistry is the source of the low-volatility compounds (23).In this paper, we present experimental results from field measurements as well as laboratory studies of nanometer particle growth and derive a plausible chemical mechanism from the results that can explain the observations of ultrafine particle growth in the marine atmosphere. The results suggest that both iodine and condensed organics contribute to particle growth from a nascent nucleation mode into an ultrafine particle mode. Moreover, laboratory studies of the growth of seed iodine oxide particles (IOP) via heterogeneous reactions with organic vapors suggest a hitherto unrecognized mechanism that fast-tracks the growth of nucleation mode clusters into survivable aerosol particles. In this process, a notable fraction of the iodine associated with these growing particles is recycled back to the gas phase, suggesting a transport mechanism for iodine to remote regions. 相似文献
68.
The evidence in support of intraocular pressure (IOP) lowering to reduce risk of glaucoma onset or progression is strong, although the amount and quality of IOP reduction is less well defined. The concept of a target IOP includes a percentage reduction, calculated IOP, or a predetermined IOP figure or range. Yet none of these strategies have been validated. In addition, our understanding of the way IOP influences glaucoma risk is continuously evolving. Examples of this include the data on IOP fluctuation and lamina cribrosa and cerebrospinal fluid pressure differentials. That these variables are not included in target IOP calculation potentially undermines its accuracy and usefulness. We summarize the evidence for target IOP, new developments in our understanding of IOP and glaucoma pathogenesis, as well as emerging strategies for setting targets and assessing response to treatment. 相似文献
69.
70.